Cholesterol restriction-mediated SREBP1 activation induces noncanonical type I IFNs, including IFN-ω and minor IFN-α subsets, ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. It is highly aggressive due to its late ...

The global Hematopoietic Stem Cell Transplantation Market is worth USD 7 Billion as of now and expected to reach USD 15 ...

The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of tumorigenesis, the TIME ...

East Ocyon Bio aims to reshape Indias role in the global biotech landscape, creating an ecosystem where pioneering therapies ...

Hepatocellular carcinoma (HCC) is a significant global health issue, ranking as the sixth most prevalent malignancy and the ...

US biotech Nektar Therapeutics has announced results of its Phase II proof-of-concept study of NKTR-255 as an adjuvant ...

Medigene announces KRAS G12V as first target for TCR-guided T cell engagers: Planegg, Germany Tuesday, December 10, 2024, 17:00 Hrs [IST] Medigene AG, an oncology platform company ...

All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and Sustained B-cell Depletion ...

GenScript Biotech, a global biotechnology leader in the life science, biologics manufacturing, synthetic biology, and cell ...

Interleukin-2 (IL-2) is a well-known cytokine that plays a crucial role in stimulating immune cells, including natural killer (NK) cells and cytotoxic T cells. It has been studied as an immunotherapy ...

目前认为，在结直肠癌根治性手术后五年内，有约20-40%的患者可能会出现癌症复发或转移。术后随访可以及时监测和处理患者可能存在的癌症复发或转移，同时还可以通过观察患者的症状、体征和影像学表现及时调整治疗方案。自然杀伤细胞（Natural killer ...